Top compounds associated with response to RUNDC3A


Feature Type Standardized
Nominal ANOVA
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.25 1e-12
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 4e-11
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.33 3e-10
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.22 6e-10
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.23 6e-10
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 4e-09
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 4e-09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 8e-09
mRNA PD-0325901 gCSI pan-cancer AAC -0.31 1e-08
Download CSV